Investors remain optimistic about QGEN due to its progress in test menu expansion and impressive prospects within its molecular diagnostics segments.

QGEN collaborates with Eli Lilly to develop a QIAstat-Dx IVD panel for APOE genotyping.

QGEN collaborates with Eli Lilly to develop a QIAstat-Dx IVD panel for APOE genotyping.

NUREMBERG, Germany— September 3, 2024 — Südwolle Group builds on existing cooperation for their Suedwebs Innovation Hub and announces the...

Press Release From: Indigenous Services Canada August, 29th, 2024 — Whitehorse (Kwanlin), Yukon on the traditional territories of the Kwanlin Dün...

Scientists at Adelphi University have uncovered evidence that an ancient Greek soldier endured a long, but painful, life despite having an arrow-head...

Scientists at Adelphi University have uncovered evidence that an ancient Greek soldier endured a long, but painful, life despite having an arrow-head...

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Infosys is collaborating with the Stanford University Institute for Human-Centered Artificial Intelligence to accelerate AI research by joining their...

SUL Education has announced a strategic partnership with CSL, marking a significant expansion into the U.S. educational sector. This collaboration...